Hernandez-Trujillo, Vivian
Zhou, Chuan
Scalchunes, Christopher
Ochs, Hans D.
Sullivan, Kathleen E.
Cunningham-Rundles, Charlotte
Fuleihan, Ramsay L.
Bonilla, Francisco A.
Petrovic, Aleksandra
Rawlings, David J.
de la Morena, M. Teresa http://orcid.org/0000-0002-0095-7262
Article History
Received: 26 December 2022
Accepted: 26 April 2023
First Online: 23 May 2023
Declarations
:
: USIDNET has developed a clinical protocol and associated informed consent documents that have been reviewed and approved by Advarra IRB.
: Not applicable<b>.</b>
: Not applicable.
: M. M. and C. Z. declare no conflict of interest. V. H. T. is on the advisory board for CSL-Behring, Regeneron, Sanofi, and Takeda. V. H. T. is a speaker and consultant for Takeda. V. H. T. is a consultant for Enzyvant and Pharming. C. S. is employed by the Immune Deficiency Foundation. D. J. R. is a recipient of research funding support from CSL-Behring.